Protein Binding of Anthraquinone Glycosides, with Special Reference to Adriamycin

Overview

Journal Cancer Chemother Pharmacol

Specialty Oncology

Date 1982 Dec 1

PMID 7160048

Citations 11

Authors

S Eksborg

H Ehrsson

B Ekqvist

Affiliations

Soon will be listed here.

Abstract

The binding of anthraquinone glycosides (adriamycin, adriamycinol, daunorubicin, daunorubicinol, and 4'epiadriamycin) to human serum albumin and human plasma has been studied by equilibrium dialysis. About 62% of adriamycin was bound to human serum albumin (45 g/l). Only minor variations in the degree of binding were observed between the anthraquinone glycosides. The binding degree of adriamycin in plasma from cancer patients was not significantly different from that observed in healthy volunteers, the fraction of free adriamycin being 24.56% +/- 4.51%, and 27.67% +/- 2.78%, respectively. The plasma albumin concentration was significantly lower in cancer patients than in the healthy volunteers (26.90% +/- 5.88% and 39.24% +/- 1.74%, respectively). In cancer patients the fraction of free adriamycin decreased with increasing plasma albumin concentration.

Citing Articles

Tuning the In Vivo Transport of Anticancer Drugs Using Renal-Clearable Gold Nanoparticles.

Peng C, Xu J, Yu M, Ning X, Huang Y, Du B Angew Chem Int Ed Engl. 2019; 58(25):8479-8483.

PMID: 31006932 PMC: 6555664. DOI: 10.1002/anie.201903256.

Pharmacokinetics of doxorubicin in pregnant women.

Ryu R, Eyal S, Kaplan H, Akbarzadeh A, Hays K, Puhl K Cancer Chemother Pharmacol. 2014; 73(4):789-97.

PMID: 24531558 PMC: 3982413. DOI: 10.1007/s00280-014-2406-z.

CE-LIF method for the separation of anthracyclines: application to protein binding analysis in plasma using ultrafiltration.

Whitaker G, Lillquist A, Pasas S, OConnor R, Regan F, Lunte C J Sep Sci. 2008; 31(10):1828-33.

PMID: 18461567 PMC: 2519822. DOI: 10.1002/jssc.200700629.

Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-beta-glucuronidase conjugate in the specific treatment of cancer.

Haisma H, Van Muijen M, Pinedo H, Boven E Cell Biophys. 1994; 24-25:185-92.

PMID: 7736523 DOI: 10.1007/BF02789229.

Intrahepatic and intravenous administration of adriamycin--a comparative pharmacokinetic study in patients with malignant liver tumours.

Eksborg S, Cedermark B, Strandler H Med Oncol Tumor Pharmacother. 1985; 2(1):47-54.

PMID: 4058077 DOI: 10.1007/BF02934780.

References

Chlebowski R, Chan K, Tong M, Weiner J, Ryden V, Bateman J . Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspects. Cancer. 1981; 48(5):1088-95. DOI: 10.1002/1097-0142(19810901)48:5<1088::aid-cncr2820480507>3.0.co;2-w. View

Brodersen R . Competitive binding of bilirubin and drugs to human serum albumin studied by enzymatic oxidation. J Clin Invest. 1974; 54(6):1353-64. PMC: 301690. DOI: 10.1172/JCI107882. View

Kornguth M, Hutchins L, Eichelman B . Binding of psychotropic drugs to isolated alpha-acid glycoprotein. Biochem Pharmacol. 2010; 30(17):2435-41. DOI: 10.1016/0006-2952(81)90338-5. View

Steele W, Lawrence J, Stuart J, McNeill C . The protein binding of methotrexate in the serum of patients with neoplastic disease. Cancer Chemother Pharmacol. 1981; 7(1):61-4. DOI: 10.1007/BF00258215. View

Piafsky K, Borga O . Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther. 1977; 22(5 Pt 1):545-9. DOI: 10.1002/cpt1977225part1545. View

Chan K, Chlebowski R, Tong M, Chen H, Gross J, Bateman J . Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis. Cancer Res. 1980; 40(4):1263-8. View

Vallner J . Binding of drugs by albumin and plasma protein. J Pharm Sci. 1977; 66(4):447-65. DOI: 10.1002/jps.2600660402. View

Borga O, Piafsky K, Nilsen O . Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate. Clin Pharmacol Ther. 1977; 22(5 Pt 1):539-44. View

MIDER G, ALLING E, Morton J . The effect of neoplastic and allied diseases on the concentrations of the plasma proteins. Cancer. 1950; 3(1):56-65. DOI: 10.1002/1097-0142(1950)3:1<56::aid-cncr2820030109>3.0.co;2-h. View

10.

Chio L, Oon C . Changes in serum alpha 1 antitrypsin, alpha1 acid glycoprotein and beta 2 glycoprotein I in patients with malignant hepatocellular carcinoma. Cancer. 1979; 43(2):596-604. DOI: 10.1002/1097-0142(197902)43:2<596::aid-cncr2820430229>3.0.co;2-r. View

11.

Kunin C . Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum. Clin Pharmacol Ther. 1966; 7(2):166-79. DOI: 10.1002/cpt196672166. View

12.

Borga O, Hamberger B, Malmfors T, Sjoqvist F . The role of plasma protein binding in the inhibitory effect of nortriptyline on the neuronal uptake of norepinephrine. Clin Pharmacol Ther. 1970; 11(4):581-8. DOI: 10.1002/cpt1970114581. View

13.

Takahashi I, Ohnuma T, Kavy S, Bhardwaj S, HOLLAND J . Interaction of human serum albumin with anticancer agents in vitro. Br J Cancer. 1980; 41(4):602-8. PMC: 2010273. DOI: 10.1038/bjc.1980.103. View

14.

Eksborg S . Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol. J Chromatogr. 1978; 149:225-32. DOI: 10.1016/s0021-9673(00)80988-7. View

15.

Carter S . Adriamycin-a review. J Natl Cancer Inst. 1975; 55(6):1265-74. DOI: 10.1093/jnci/55.6.1265. View

16.

Bonfante V, Bonadonna G, Villani F, Martini A . Preliminary clinical experience with 4-epidoxorubicin in advanced human neoplasia. Recent Results Cancer Res. 1980; 74:192-9. DOI: 10.1007/978-3-642-81488-4_24. View

17.

Eksborg S . Extraction of daunorubicin and doxorubicin and their hydroxyl metabolites: self-association in aqueous solution. J Pharm Sci. 1978; 67(6):782-5. DOI: 10.1002/jps.2600670613. View

18.

Piafsky K, Borga O, Odar-Cederlof I, Johansson C, Sjoqvist F . Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med. 1978; 299(26):1435-9. DOI: 10.1056/NEJM197812282992604. View

19.

Benjamin R, Wiernik P, Bachur N . Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer. 1974; 33(1):19-27. DOI: 10.1002/1097-0142(197401)33:1<19::aid-cncr2820330107>3.0.co;2-m. View

20.

HOLLINSHEAD A, Chuang C, Cooper E, Catalona W . Interrelationship of prealbumin and alpha-1 acid glycoprotein in cancer patient sera. Cancer. 1977; 40(6):2993-8. DOI: 10.1002/1097-0142(197712)40:6<2993::aid-cncr2820400635>3.0.co;2-i. View